Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model

被引：0
|
作者：
Min-Sun Kwak
Su Jong Yu
Jung-Hwan Yoon
Sung-Hee Lee
Soo-Mi Lee
Jeong-Hoon Lee
Yoon Jun Kim
Hyo-Suk Lee
Chung Yong Kim
机构：
[1] Seoul National University College of Medicine,Department of Internal Medicine and Liver Research Institute
[2] Seoul National University Hospital,Department of Internal Medicine, Healthcare Research Institute, Healthcare System Gangnam Center
来源：
Journal of Cancer Research and Clinical Oncology | 2015年 / 141卷
关键词：
Hepatocellular carcinoma; Doxorubicin; Flavopiridol; Apoptosis; Hypoxia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2037 / 2045
页数：8
相关论文
共 50 条
  • [1] Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model
    Kwak, Min-Sun
    Yu, Su Jong
    Yoon, Jung-Hwan
    Lee, Sung-Hee
    Lee, Soo-Mi
    Lee, Jeong-Hoon
    Kim, Yoon Jun
    Lee, Hyo-Suk
    Kim, Chung Yong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (11) : 2037 - 2045
  • [2] Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
    Cheng, Yang
    Luo, RongCheng
    Zheng, Hang
    Wang, Biao
    Liu, YaHui
    Liu, DingLi
    Chen, JinZhang
    Xu, WanFu
    Li, AiMin
    Zhu, Yun
    ONCOTARGET, 2017, 8 (14) : 23265 - 23276
  • [3] Synergistic anti-tumor efficacy of statin and protein kinase C inhibitor in hepatocellular carcinoma
    Yoon, J. H.
    Kim, W.
    Myung, S. J.
    Lee, J. S.
    Lee, Y. J.
    Kim, Y. J.
    Lee, H. S.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S118 - S118
  • [4] Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo
    Li, Lian-Kun
    Kuang, Wen-Juan
    Huang, Yun-Feng
    Xie, Han-Hong
    Chen, Guo
    Zhou, Qing-Chun
    Wang, Bin-Rong
    Wan, Li-Hong
    INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (01) : 78 - 81
  • [5] Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma
    Won Kim
    Jung-Hwan Yoon
    Jung-Ryul Kim
    In-Jin Jang
    Yung-Jue Bang
    Yoon-Jun Kim
    Hyo-Suk Lee
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 497 - 507
  • [6] Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma
    Kim, Won
    Yoon, Jung-Hwan
    Kim, Jung-Ryul
    Jang, In-Jin
    Bang, Yung-Jue
    Kim, Yoon-Jun
    Lee, Hyo-Suk
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (03) : 497 - 507
  • [7] SYNERGISTIC ANTI-TUMOR EFFECT OF SORAFENIB IN COMBINATION WITH AKT INHIBITORS IN HEPATOCELLULAR CARCINOMA
    Feng, W. -C.
    Hsu, C. -H.
    Lin, S. -D.
    Lin, H. -H.
    Hsu, D. -W.
    Huang, C. -C.
    Chow, L. -P.
    Cheng, A. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 16 - 16
  • [8] Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
    Ou, Da-Liang
    Chang, Chun-Jung
    Jeng, Yung-Ming
    Lin, Yi-Jang
    Lin, Zhong-Zhe
    Gandhi, Anita K.
    Liao, Sheng-Chieh
    Huang, Zi-Ming
    Hsu, Chiun
    Cheng, Ann-Lii
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (12) : 2021 - 2031
  • [9] Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma
    Chow, Ariel K. M.
    Ng, Lui
    Li, Hung Sing
    Cheng, Chi Wai
    Lam, Colin S. C.
    Yau, Thomas C. C.
    Cheng, Paul N. M.
    Fan, Sheung Tat
    Poon, Ronnie T. P.
    Pang, Roberta W. C.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (09) : 1233 - 1243
  • [10] Anti-tumor efficacy employing oncolytic adenovirus specific for hepatocellular carcinoma
    Li, YH
    Chen, Y
    Amin, P
    Henderson, D
    Yu, DC
    CANCER GENE THERAPY, 2001, 8 : S16 - S16
12345